|Need medication advice by Tuesday, your time
Feb 13, 2011
I live in Thailand, and was just diagnosed positive on Jan. 22, 2011, after testing negative at one month and three+ months after a possible exposure.
On Jan. 24, my VL = 60,883; CD4's=403
I have had symptoms since August, 2010 with fatigue and intermittent, low grade fevers.
Since I am treatment naive, my physician ordered genotyping and resistance testing - it came back today: HIV-1, with no detectable mutations; It showed 100% susceptible to ALL medications in ALL categories.
I have been reading a lot and think Atripola is a good choice for my treatment regimen. My doc has access to the three ingredients, separately, but not tucked into one tidy pill.
My question: Can I take the three drugs, individually, following the Atripola protocol; once a day, at bed time (three pills, or even possibly in two)?
Any thoughts or specifications would be VERY helpful!
| Response from Dr. Young
Hi and thanks for your post from Thailand!
Yes indeed, Atripla is very popular here-- it is the combination of three HIV medications, tenofovir (known also as Viread), emtricitabine (Emtriva, FTC) and efavirenz (Sustiva, Stocrin). Back in the day, the combination was achieved just as you describe, namely three pills (using the cousin of FTC, 3TC) all taken once daily.
There's no reason why you can't take your three at once.
Hope this is helpful, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.